Mette Lauritzen is a Market Product Manager for Nuclear Molecular Imaging at Bruker BioSpin in Germany. She has an academic background in preclinical MRI and PET Imaging, having completed her PhD at the Danish Research Centre for Magnetic Resonance (DRCMR) and post-doctoral position at Stanford University, School of Medicine’s Radiology Department.